Comprehensive chromosome screening with synchronous blastocyst transfer Time for a paradigm shift
Recently, the nature of assisted reproductive technology (ART) laboratory investigation has been shifting. Traditionally, it has focused on optimizing the culture milieu or assuring fertilization; now, a variety of new technologies are available to assess the reproductive potential of individual embryos. Perhaps most prominent has been the resurgence of embryonic aneuploidy screening. The validation of 24-chromosome testing platforms has led to a variety of studies demonstrating higher implantation and delivery rates.
Authors
Richard Scott Jr., M.D., Jason M. Franasiak, M.D., Eric J. Forman, M.D.
Volume 102, Issue 3, Pages 660-661
Abstract
Recently, the nature of assisted reproductive technology (ART) laboratory investigation has been shifting. Traditionally, it has focused on optimizing the culture milieu or assuring fertilization; now, a variety of new technologies are available to assess the reproductive potential of individual embryos. Perhaps most prominent has been the resurgence of embryonic aneuploidy screening. The validation of 24-chromosome testing platforms has led to a variety of studies demonstrating higher implantation and delivery rates.
Read the full text at: http://www.fertstert.org/article/S0015-0282(14)00568-8/fulltext
